Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions
- PMID: 24477413
- PMCID: PMC4009626
- DOI: 10.1007/s11914-014-0188-1
Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions
Abstract
The SOST gene, which encodes the protein sclerostin, was identified through genetic linkage analysis of sclerosteosis and van Buchem's disease patients. Sclerostin is a secreted glycoprotein that binds to the low-density lipoprotein receptor-related proteins 4, 5, and 6 to inhibit Wnt signaling. Since the initial discovery of sclerostin, much understanding has been gained into the role of this protein in the regulation of skeletal biology. In this article, we discuss the latest findings in the regulation of SOST expression, sclerostin mechanisms of action, and the potential utility of targeting sclerostin in conditions of low bone mass.
Conflict of interest statement
MM Weivoda declares no conflicts of interest.
MJ Oursler declares no conflicts of interest.
References
-
- van Bezooijen R, ten Dijke P, Papapoulos SE, Lowik CWGM. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine & Growth Factor Reviews. 2005;16:319–327. - PubMed
-
- Balemans W, Van Den Ende J, Freire Paes-Alves A, Dikkers, Willems PJ, Vanhoenacker F, de Almeida-Melo N, Freire Alves C, Stratakis CA, Hill SC, Van Hul W. Localization of the Gene for Sclerosteosis to the van Buchem Disease-Gene Region on Chromosome 17q12-q21. Am J Hum Genet. 1999;64:1661–1669. - PMC - PubMed
-
- Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum Molec Genet. 2001;10(5):537–543. - PubMed
-
- Brunkow M, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu YH, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan JT. Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot- Containing Protein. Am J Hum Genet. 2001;68:577–589. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
